Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Excessive cortical beta oscillations are associated with slow-wave sleep dysfunction in mild parkinsonism.
Verma AK, Nandakumar B, Acedillo K, Yu Y, Marshall E, Schneck D, Fiecas M, Wang J, MacKinnon CD, Howell MJ, Vitek JL, Johnson LA. Verma AK, et al. Among authors: mackinnon cd. bioRxiv [Preprint]. 2023 Nov 1:2023.10.28.564524. doi: 10.1101/2023.10.28.564524. bioRxiv. 2023. Update in: Front Neurosci. 2024 Feb 21;18:1338624. doi: 10.3389/fnins.2024.1338624. PMID: 37961389 Free PMC article. Updated. Preprint.
Low-frequency deep brain stimulation reveals resonant beta-band evoked oscillations in the pallidum of Parkinson's Disease patients.
Zapata Amaya V, Aman JE, Johnson LA, Wang J, Patriat R, Hill ME, MacKinnon CD, Cooper SE, Darrow D, McGovern R, Harel N, Molnar GF, Park MC, Vitek JL, Escobar Sanabria D. Zapata Amaya V, et al. Among authors: mackinnon cd. Front Hum Neurosci. 2023 Sep 22;17:1178527. doi: 10.3389/fnhum.2023.1178527. eCollection 2023. Front Hum Neurosci. 2023. PMID: 37810764 Free PMC article.
Comorbid neurotrauma increases neurodegenerative-relevant cognitive, motor, and autonomic dysfunction in patients with rapid eye movement sleep behavior disorder: a substudy of the North American Prodromal Synucleinopathy Consortium.
Elliott JE, Ligman BR, Bryant-Ekstrand MD, Keil AT, Powers K, Olivo C, Neilson LE, Postuma RB, Pelletier A, Gagnon JF, Gan-Or Z, Yu E, Liu L, St Louis EK, Forsberg LK, Fields JA, Ross OA, Huddleston DE, Bliwise DL, Avidan AY, Howell MJ, Schenck CH, McLeland J, Criswell SR, Videnovic A, During EH, Miglis MG, Shprecher DR, Lee-Iannotti JK, Boeve BF, Ju YS, Lim MM; North American Prodromal Synucleinopathy (NAPS) Consortium. Elliott JE, et al. Sleep. 2024 Jun 13;47(6):zsae007. doi: 10.1093/sleep/zsae007. Sleep. 2024. PMID: 38181205
Neural pathways associated with reduced rigidity during pallidal deep brain stimulation for Parkinson's disease.
Lecy E, Linn-Evans ME, Amundsen-Huffmaster SL, Palnitkar T, Patriat R, Chung JW, Noecker AM, Park MC, McIntyre CC, Vitek JL, Cooper SE, Harel N, Johnson MD, MacKinnon CD. Lecy E, et al. Among authors: mackinnon cd. J Neurophysiol. 2024 Sep 1;132(3):953-967. doi: 10.1152/jn.00155.2024. Epub 2024 Aug 7. J Neurophysiol. 2024. PMID: 39110516 Free PMC article.
Baseline characteristics of the North American prodromal Synucleinopathy cohort.
Elliott JE, Lim MM, Keil AT, Postuma RB, Pelletier A, Gagnon JF, St Louis EK, Forsberg LK, Fields JA, Huddleston DE, Bliwise DL, Avidan AY, Howell MJ, Schenck CH, McLeland J, Criswell SR, Videnovic A, During EH, Miglis MG, Shprecher DR, Lee-Iannotti JK, Boeve BF, Ju YS; North American Prodromal Synucleinopathy (NAPS) Consortium. Elliott JE, et al. Ann Clin Transl Neurol. 2023 Apr;10(4):520-535. doi: 10.1002/acn3.51738. Epub 2023 Feb 8. Ann Clin Transl Neurol. 2023. PMID: 36751940 Free PMC article. Clinical Trial.
Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial.
Patterson CG, Joslin E, Gil AB, Spigle W, Nemet T, Chahine L, Christiansen CL, Melanson E, Kohrt WM, Mancini M, Josbeno D, Balfany K, Griffith G, Dunlap MK, Lamotte G, Suttman E, Larson D, Branson C, McKee KE, Goelz L, Poon C, Tilley B, Kang UJ, Tansey MG, Luthra N, Tanner CM, Haus JM, Fantuzzi G, McFarland NR, Gonzalez-Latapi P, Foroud T, Motl R, Schwarzschild MA, Simuni T, Marek K, Naito A, Lungu C, Corcos DM; SPARX3-PSG Investigators. Patterson CG, et al. Trials. 2022 Oct 6;23(1):855. doi: 10.1186/s13063-022-06703-0. Trials. 2022. PMID: 36203214 Free PMC article.
87 results